This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

7 Health Care Stocks for 2012

4. Masimo (MASI - Get Report) develops, manufactures, and markets non-invasive patient monitoring products to improve patient care. Its Masimo Signal Extraction Technology (Masimo SET) provides the capabilities of Measure-Through Motion and Low Perfusion pulse oximetry.

For the third quarter 2011, revenue, including royalties, rose 3% to $104.0 million, vs. 2010 quarter. Product revenue rose 10% to $97.6 million, whereas worldwide end-user business grew 18%. The company shipped 33,400 Masimo SET and Masimo rainbow SET units, expanding worldwide installed base by 16%.

For fiscal 2011, MASI estimates total revenue in the range of $436 million to $439 million, including product revenue between $404 million and $407 million, and royalty revenue between $31.5 million and $32.5 million.

MASI has received the American Association of Respiratory Care (AARC) prestigious Zenith award for the fourth straight year.

Of the 15 analysts covering the stock, 53% recommend a buy and 40% suggest a hold. The stock's average 12-month price target is $25.05, or 37.7% above the current price, according a Bloomberg consensus.

4 of 7

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
HMA $0.00 0.00%
CERN $67.29 -1.52%
HCA $81.83 0.04%
HLS $43.16 -0.48%
MASI $35.10 -1.07%

Markets

DOW 18,010.68 -115.44 -0.64%
S&P 500 2,107.39 -13.40 -0.63%
NASDAQ 5,070.0260 -27.95 -0.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs